Fundamental research is the basis for understanding and treatment of many human diseases
- 21 June 2006
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 580 (23) , 5430-5435
- https://doi.org/10.1016/j.febslet.2006.06.025
Abstract
There are numerous examples of how fundamental research has been required to understand and treat human disease. This article focuses on three human diseases of lipid metabolism in which advancements in understanding and treatment would not have been possible without basic research. Fabry disease is an inherited metabolic disorder caused by the lack of a specific enzyme in glycosphingolipid catabolism. Cardiovascular disease is a complex and multifactorial disease but as many as half of the cases can be attributed to abnormal levels of plasma cholesterol. The incidence of liver disease is increasing due to the current epidemic of obesity. It is only recently that curiosity-driven research has yielded valuable insight into the mechanism by which liver disease evolves.Keywords
This publication has 47 references indexed in Scilit:
- Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it—almostJournal of Lipid Research, 2006
- Enzyme replacement therapy for Fabry disease: lessons from two α-galactosidase A orphan products and one FDA approvalExpert Opinion on Biological Therapy, 2004
- Cholesterol in the year 2000Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- CTP:phosphocholine cytidylyltransferaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1997
- A Genetic Defect in Phosphatidylcholine Biosynthesis Triggers Apoptosis in Chinese Hamster Ovary CellsPublished by Elsevier ,1996
- Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assemblyBiochemistry and Cell Biology, 1990
- Regulation of phosphatidylcholine biosynthesisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1984
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Gas chromatography of sugars and other polyhydroxy compoundsBiochemical and Biophysical Research Communications, 1963
- Methyl transfering enzyme system of microsomes in the biosynthesis of lecithin (phosphatidylcholine)Biochimica et Biophysica Acta, 1961